You are here

LentiGlobin

ASH 2021 – Bluebird looks to revive Lentiglobin

EP Vantage

Mon, 12/13/21 - 10:34 am

sickle cell disease

With LentiGlobin cleared by FDA, bluebird lifts EU marketing hold on gene therapy using the same delivery mechanism

Endpoints

Fri, 07/9/21 - 09:54 am

sickle cell disease

beta thalassemia

Bluebird seeks gene therapy trial restart after cancer scare

Pharmaforum

Wed, 03/10/21 - 11:27 am

sickle cell disease

EHA 2020 – Bluebird’s sickle cell plan takes shape, with a stark reminder

EP Vantage

Fri, 06/12/20 - 10:41 am

sickle cell disease

FDA Mishaps Have Investors Asking “What’s Going On With bluebird bio?”

Motley Fool

Sun, 05/24/20 - 10:19 pm

beta thalassemia

clinical trials

Bluebird says gene therapy application delayed again, citing disagreement with FDA

BioPharma Dive

Thu, 03/26/20 - 11:57 pm

LentiGlobin gene therapy for sickle cell on course for filing, says bluebird

Pharmaforum

Wed, 12/11/19 - 09:50 pm

sickle cell disease

Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big

Motley Fool

Sun, 05/19/19 - 04:05 pm

Aimmune Therapeutics

Orphan drugs market to soar to $224bn by 2024

PM Live

Fri, 04/26/19 - 08:18 pm

Evaluate Pharma

2 Blockbuster Gene Therapy Programs to Watch in 2019

Motley Fool

Sun, 03/31/19 - 03:42 pm

First gene therapy to treat rare blood disease nears European approval

Stat

Fri, 03/29/19 - 10:05 am

beta-thalassemia

bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire

BioSpace

Fri, 03/22/19 - 10:06 pm

drug manufacturing

Where Will bluebird bio Be in 5 Years?

Motley Fool

Thu, 01/24/19 - 11:41 am

bluebird's five-year pricing model for LentiGlobin could resonate with payers

BioCentury

Wed, 01/9/19 - 09:21 am

EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder

CP Wire

Fri, 10/5/18 - 09:50 am

transfusion-dependent anemia

EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder

Fri, 10/5/18 - 09:18 am

transfusion-dependent anemia

Bluebird’s first gene therapy gets European fast track

PM Live

Sat, 07/28/18 - 12:26 pm

Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far

Motley Fool

Mon, 07/9/18 - 10:48 am

beta thalassemia

Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives

Yahoo/Benzinga

Sun, 06/24/18 - 09:32 pm

Madrigal Pharmaceuticals

Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease

CP Wire

Fri, 06/15/18 - 10:02 am

sickle cell disease

Pages